NCT02827565View on ClinicalTrials.gov

Technical Optimization of Detection of KRAS, BRAF and NRAS Mutations on Tumor DNA Circulating in Metastatic Colorectal Cancer

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 3, 2016

Primary Completion Date

January 5, 2017

Study Completion Date

January 19, 2017

Conditions
Metastatic Colorectal Cancer
Interventions
OTHER

KRAS, NRAS et BRAF mutation analysis from circulating plasma DNA

10 ml blood sample

Trial Locations (1)

54500

Institut de Cancerologie de Lorraine, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Institut de Cancérologie de Lorraine

OTHER

NCT02827565 - Technical Optimization of Detection of KRAS, BRAF and NRAS Mutations on Tumor DNA Circulating in Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter